Abstract
The vitamin folic acid (FA) is essential for DNA synthesis, repair and methylation, and for methionine synthesis. Although it is necessary for neural development, recent studies suggest a possible link between excess maternal supplemental FA intake and adverse interferences with single-carbon metabolism and neural development. Insufficient FA early in brain development can lead to failure of the neural tube closure, but the consequences of too much intake have not been fully investigated. Plasma FA concentrations can increase greatly with dietary supplementation. To model the development of neural connectivity, we cultured dorsal root ganglia (DRGs) taken from 8-day-old chick embryos in a range of pteroylmonoglutamate (PteGlu, synthetic supplemental FA) concentrations. DRGs were cultured for 36 h, fixed and immunostained to reveal the locations of neural networks with synaptic vesicles. We found a concentration-dependent relationship with significant reduction in neurite length in PteGlu concentrations from 0.25 to 20 μM. The average total of stained synaptic areas surrounding each cultured DRG was significantly reduced as well. To further characterize the effects, we carried out time-lapse imaging of growth cones at terminals of extending neurites. We found that PteGlu reduced the area-changing activity of the growth cone, hindering its exploratory capabilities, along with a tendency to inhibit overall advancement, thus altering the ability to extend and form synapses. Our results show that PteGlu at 250 nM and higher reduces neurite extension and synapse formation in a dose-dependent manner during neurogenesis, and that its effect is mediated through inhibition of growth cone motility.
References
1.
Avali, E.E., N.E. Skacel, H. Celikkaya, Y.C. Hsieh (2008) Regulation of human dihydrofolate reductase activity and expression; in Litwack, G. (ed): Folic Acid and Folate. London, Elsevier, vol 79, pp 267-287.
2.
Bailey, L.B., J.F. Gregory III (1999) Folate metabolism and requirements. J Nutr 129: 779-782.
3.
Bailey S.W., J.E. Ayling (2009) The extremely slow and variable activity of dihydrofolate reductase in human liver and its implications for high folic acid intake. Proc Natl Acad Sci USA 106: 15424-15429.
4.
Barua, B., K.K. Chadman, S. Kuizon, D. Buenaventura, N.W. Stapley, F. Ruocco, U. Begum, S.R. Guariglia, W.T. Brown, M.A. Juniad (2014) Increasing maternal or post-weaning folic acid alters gene expression and moderately changes behavior in the offspring. PLoS One 9: e101674.
5.
Barua, S., S. Kuizon, K.K. Chadman, W.T. Brown, M. Juniad (2015) Microarray analysis reveals higher gestational folic acid alters expression of genes in the cerebellum of mice offspring - a pilot study. Brain Sci 5: 14-31.
6.
Beard, C.M., L.A. Panser, S.K. Katusic (2011) Is excess folic acid supplementation a risk factor for autism? Med Hypotheses 77: 15-17.
7.
Brochner, C.B., C.B. Holst, K. Mollgard (2015) Outer brain barriers in rat and human development. Front Neurosci 9: 75.
8.
Chatzi, L., E. Papadopoulou, K. Koutra, T. Roumeliotaki, V. Georgiou, N. Stratakis, V. Lebentakou, M. Karachaliou, M. Vassilaki, M. Kogevinas (2012) Effect of high doses of folic acid supplementation in early pregnancy on child neurodevelopment at 18 months of age: the mother-child cohort ‘Rhea' study in Crete, Greece. Public Health Nutr 15: 1728-1736.
9.
Choi, J.-H., Z. Yates, M. Veysey, Y.-R. Heo, M. Lucock (2014) Contemporary issues surrounding folic acid fortification initiatives. Prev Nutr Food Sci 19: 247-260.
10.
Cohen, S., R. Levi-Montalcini, V. Hamburger (1954) A nerve growth-stimulating factor isolated from sarcomas 37 and 180. Proc Natl Acad Sci USA 40: 1014-1018.
11.
Crider, K.S., L.B. Bailey, R.J. Berry (2011) Folic acid food fortification - its history, effect, concerns, and future directions. Nutrients 3: 370-384.
12.
De Graaf-Peters, V.B., M. Hadders-Algra (2005) Ontogeny of the human central nervous system: what is happening when? Early Hum Dev 82: 257-266.
13.
DeSoto, M.C., R. Hitlan (2012) Synthetic folic acid supplementation during pregnancy may increase the risk of developing autism. J Pediatr Biochem 2: 251-261.
14.
Ebert, D. H., M.E. Greenberg (2013) Activity-dependent neuronal signaling and autism spectrum disorder. Nature 493: 327-337.
15.
Fischbach, F., M.B. Dunning (2008) A Manual of Laboratory and Diagnostic Tests, ed 8. Philadelphia, Lippincott Williams & Wilkins.
16.
Gill, I., S. Droubi, S. Giovedi, K.N. Fedder, L.A. Bury, F. Bosco, M.P. Sceniak, F. Benfenati, S.L. Sabo (2015) Presynaptic NMDA receptors - dynamics and distribution in developing axons in vitro and in vivo. J Cell Sci 128: 768-780.
17.
Girotto, F., L. Scott, Y. Avchalumov, J. Harris, S. Iannattone, C. Drummond-Main, R. Tobias, L. Bello-Espinosa, J.M. Rho, J. Davidsen, G.C. Teskey, M.A. Colicos (2013) High dose folic acid supplementation of rats alters synaptic transmission and seizure susceptibility in offspring. Sci Rep 3: 1465.
18.
Hoyo, C., A.P. Murtha, J.M. Schildkraut (2011) Folic acid supplementation before and during pregnancy in the Newborn Epigenetics STudy (NEST). BMC Public Health 11: 46.
19.
Hunter, R., J. Barnes, H.F. Oakeley, D.M. Matthews (1970) Toxicity of folic acid given in pharmacological doses to healthy volunteers. Lancet 295: 61-63.
20.
Institute of Medicine (US) Standing Committee on the Scientific Evaluation of Dietary Reference Intakes and Its Panel on Folate, Other B Vitamins, and Choline (1998): Dietary Reference Intakes for Thiamine, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Pantothenic Acid, Biotin and Choline. Washington, National Academies Press, http://www.ncbi.nlm.nih.gov/books/NBK114318/.
21.
James, S., S. Melnyk, S. Jernigan, M.A. Cleves, C.H. Halsted, D.H. Wong, P. Cutler, K. Bock, M. Boris, J.J. Broadstreet, S.M. Baker, D.W. Gaylor (2006) Metabolic endophenotype and related genotypes are associated with oxidative stress in children with autism. Am J Med Genet 141B: 947-56.
22.
James, S.J., S. Melnyk, S. Jernigan, O. Pavoiv, T. Trusty, S. Lehman, L. Seidel, D.W. Gaylor, M.A. Cleves (2010) A functional polymorphism in the reduced folate carrier gene and DNA hypomethylation in mothers of children with autism. Am J Med Genet B Neuropsychiatr Genet 153B: 1209-1220.
23.
Kao, T.T., K.C. Wang, W.N. Chang, C.Y. Lin, B.H. Chen, H.L. Wu, G.Y. Shi, J.N. Tsai, T.F. Fu (2008) Characterization and comparative studies of zebrafish and human recombinant dihydrofolate reductases - inhibition by folic acid and polyphenols. Drug Metab Dispos 36: 508-516.
24.
Kalmbach, R.D., S.F. Choumenkovitch, A.M. Troen, R. D'Agostino, P.F. Jacques, J. Selhub (2008) Circulating folic acid in plasma: relation to folic acid fortification. Am J Clin Nutr 88: 763-768.
25.
Kelly, P., J. McPartlin, M. Goggins, D.G. Weir, J.M. Scott (1997) Unmetabolized folic acid in serum: acute studies in subjects consuming fortified food and supplements. Am J Clin Nutr 65: 1790-1795.
26.
Krakowiak, P., C.K. Walker, A.A. Bremer, A.S. Baker, S. Ozonoff, R.L. Hansen, I. Hertz-Picciotto (2012) Maternal metabolic conditions and risk for autism and other neurodevelopmental disorders. Pediatrics 129: 1-8.
27.
Leeming, R.J., M. Lucock (2009) Autism: is there a folate connection? J Inherit Metab Dis 32: 400-402.
28.
Letourneau, P.C. (1975) Possible roles for cell-to-substratum adhesion in neuronal morphogenesis. Dev Biol 44: 77-91.
29.
Levi-Montalcini, R. (1964) Growth control of nerve cells by a protein factor and its antiserum. Science 143: 105-110.
30.
Lucock, M., R. Leeming (2013) Autism, seasonality and the environmental perturbation of epigenome related vitamin levels. Med Hypotheses 80: 750-755.
31.
Milunsky, A., H. Jick, S.S. Jick, C.L. Bruell, D.S. MacLaughlin, K.J. Rothman, W. Willett (1989) Multivitamin/folic acid supplementation in early pregnancy reduces the prevalence of neural tube defects. JAMA 262: 2847-2852.
32.
Mulinare, J., J.F. Cordero, J.D. Erickson, R.J. Berry (1988) Periconceptional use of multivitamins and the occurrence of neural tube defects. JAMA 260: 3141-3145.
33.
Neale, B.M., Y. Kou, L. Liu, A. Ma'ayan, K.E. Samocha, A. Sabo, C.-R. Lin, C. Stevens, L.-S. Wang, V. Makarov, P. Polak, S. Yoon, J. Maguire, E.L. Crawford, N.G. Campbell, E.T. Geller, O. Valladares, C. Schafer, H. Liu, T. Zhao, G. Cai, J. Lihm, R. Dannenfelser, O. Jabado, Z. Peralta, U. Nagaswamy, D. Muzny, J.G. Reid, I. Newsham, Y. Wu, L. Lewis, Y. Han, B.F. Voight, E. Lim, E. Rossin, A. Kirby, J. Flannick, M. Fromer, K. Shakir, T. Fennell, K. Garimella, E. Banks, R. Poplin, S. Gabriel, M. DePristo, J.R. Wimbish, B.E. Boone, S.E. Levy, C. Betancur, S. Sunyaev, E. Boerwinkle, J.D. Buxbaum, E.H. Cook Jr., B. Devlin, R.A. Gibbs, K. Roeder, G.D. Schellenberg, J.S. Sutcliffe, M.J. Daly (2012) Patterns and rates of exonic de novo mutations in autism spectrum disorders. Nature 485: 242-245.
34.
Obeid, R., M. Kasoha, S.H. Kirsch, W. Munz, W. Herrmann (2010) Concentrations of unmetabolized folic acid and primary folate forms in pregnant women at delivery and in umbilical cord blood. Am J Clin Nutr 92: 1416-1422.
35.
Reynolds, E.H. (2002) Benefits and risks of folic acid to the nervous system. J Neurol Neurosurg Psychiatry 72: 567-571.
36.
Rogers, E.J. (2008) Has enhanced folate status during pregnancy altered natural selection and possibly autism prevalence? A closer look at a possible link. Med Hypotheses 71: 406-410.
37.
Roidl, D., C. Hacker (2014) Histone methylation during neural development. Cell Tissue Res 356: 539-552.
38.
Rosenquist, T.H. (2013) Folate, homocysteine and the cardiac neural crest. Dev Dyn 242:201-218.
39.
Roy, S., A. Kale, K. Dangat, P. Sable, A. Kulkarni, S. Joshi (2012) Maternal micronutrients (folic acid and vitamin (B12)) and omega 3 fatty acids: implications for neurodevelopmental risk in the rat offspring. Brain Dev 34: 64-71.
40.
Saunders, N.R., M.D. Habgood, K.M. Dziegielewska (1999) Barrier mechanisms in the brain, II. Immature brain. Clin Exp Pharmacol Physiol 26: 85-91.
41.
Schneider, C.A., W.S. Rasband, K.W. Eliceiri (2012) NIH Image to ImageJ: 25 years of image analysis. Nat Methods 9: 671-675.
42.
Shane, B. (2010) Folate chemistry and metabolism; in Bailey, L.B. (ed): Folate in Health and Disease. New York, CRC Press, pp 2-3.
43.
Smith, A.D., Y.I. Kim, H. Refsum (2008) Is folic acid good for everyone? Am J Clin Nutr 87: 517-533.
44.
Smithells, R.W., N.C. Nevin, M.J. Seller, S. Sheppard, R. Harris, A.P. Read, D.W. Fielding, S. Walker, C.J. Schorah, J. Wild (1983) Further experience of vitamin supplementation for prevention of neural tube defect recurrences. Lancet 1: 1027-1031.
45.
Smithells, R.W., S. Sheppard, C.J. Schorah, M.J. Seller, N.C. Nevin, R. Harris, A.P. Read, D.W. Fielding (1980) Possible prevention of neural-tube defects by periconceptional vitamin supplementation. Lancet 1: 339-340.
46.
Suren, P., C. Roth, M. Bresnahan, M. Haugen, M. Hornig, D. Hirtz, K.K. Lie, W.I. Lipkin, P. Magnus, T.R. Reichborn-Kjennerud, S. Schjolberg, G.D. Smith, A-A. Oyen, E. Susser, C. Stoltenberg (2013) Association between maternal use of folic acid supplements and risk of autism spectrum disorders in children. JAMA 309: 570-577.
47.
Troen, A.M., B. Mitchell, B. Sorensen, M.H. Wener, A. Johnston, B. Wood, J. Selhum, A. McTiernan, Y. Yasui, J.D. Potter, C.M. Ulrich (2006) Unmetabolized folic acid in plasma is associated with reduced natural killer cell cytotoxicity among postmenopausal women. J Nutr 136: 189-194.
48.
US Department of Health and Human Services (2012) Prevalence of autism spectrum disorders - Autism and Developmental Disabilities Monitoring Network, 14 sites, United States, 2008. MMWR Surveill Summ 61: 1-19.
49.
US Food and Drug Administration (1996) FDA food standards: amendments of standards of identity for enriched grain products to require addition of folic acid. Fed Regist 61: 8781-8807.
50.
Wagner, C. (1995) Biochemical role of folate in cellular metabolism; in Bailey, L.B. (ed): Folate in Health and Disease. New York, Dekker, pp 23-42.
51.
Wald, D., L. Bishop, N.J. Wald, M. Law, E. Hennessy, D. Weir, J. McPartlin, J. Scott (2001) Randomized trial of folic acid supplementation and serum homocysteine levels. Arch Intern Med 161: 695-700.
52.
Wang, P.Y., R.S. Petralia, Y.X. Wang, R.J. Wenthold, S.D. Brenowitz (2011) Functional NMDA receptors at axonal growth cones of young hippocampal neurons. J Neurosci 31: 9289-9297.
© 2016 S. Karger AG, Basel
2016
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
